Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 6 Issue 5, May 2006

From The Editors

Top of page ⤴

Research Highlight

Top of page ⤴

In the News

Top of page ⤴

Research Highlight

Top of page ⤴

Review Article

  • The use of antibodies as therapeutic agents is a big business, with 18 now approved for use in the United States. How they are generated and optimized to increase efficacy and safety is the focus of extensive research efforts, which are reviewed here.

    • Paul J. Carter
    Review Article
  • Statins are best known as cholesterol-lowering drugs but increasing evidence indicates that they might be an effective treatment for autoimmune disease. Their ability to inhibit post-translational protein prenylation could be key to their immunomodulatory effects.

    • John Greenwood
    • Lawrence Steinman
    • Scott S. Zamvil
    Review Article
  • With the search for an HIV vaccine still ongoing, attention is turning towards developing topical prevention strategies that prevent HIV transmission. This Review describes the rationale behind the choice of targets for such strategies and how their clinical development is progressing.

    • Michael M. Lederman
    • Robin E. Offord
    • Oliver Hartley
    Review Article
  • This Review discusses recent studies that have identified ways to increase the antitumour response of autologous tumour-reactive cells adoptively transferred to individuals with cancer, such as the use of lymphodepleting regimens before adoptive cell transfer.

    • Luca Gattinoni
    • Daniel J. Powell Jr.
    • Nicholas P. Restifo
    Review Article
  • Clinical trials of reagents that target B cells in individuals with autoimmune disease, in particular rheumatoid arthritis, have yielded highly promising results. Might such an approach bring us closer to the goal of re-establishing immune tolerance in these individuals?

    • Jonathan C. W. Edwards
    • Geraldine Cambridge
    Review Article
  • Although the discontinuation of a clinical trial of amyloid-β vaccination of subjects with Alzheimer's disease led us to reassess the use of immune-based therapy for this disease, subsequent work involving antibody and cell-based therapies looks promising.

    • Howard L. Weiner
    • Dan Frenkel
    Review Article
Top of page ⤴

Opinion

Top of page ⤴

Correspondence

Top of page ⤴

Focus

  • Immunology is one of the few disciplines that straddle both basic sciences and applied medicine, and translating what we observe in the laboratory to the clinic is an increasingly important goal for many immunologists. This Focus highlights how basic research findings are being translated and applied to the treatment of cancer, and autoimmune and infectious diseases.

    Focus
Top of page ⤴

Search

Quick links